APP and Alzheimer disease: Moreover, the researchers also demonstrated that the injection of 3NTyr10-Aβ into the brain of young APP/PS1 mice induced β-amyloidosis, suggesting that modulation of iNOS activity could be a potential therapeutic option to treat AD [149].